ICU Medical Inc. agreed to buy Pfizer Inc.’s infusion-systems business in a $1 billion cash-and-stock deal, giving the California medical-device maker a larger footprint in the global market. Under the deal’s terms, ICU Medical will acquire Pfizer’s Hospira Infusion Systems business for $400 million in newly issued shares. This would give Pfizer a 16.6% stake in ICU Medical and the right to nominate one director to the company’s...

Source: Wall Street Journal October 06, 2016 13:30 UTC